Katila H, Appelberg B, Hurme M, Rimón R
Helsinki University Central Hospital, Department of Psychiatry, Finland.
Schizophr Res. 1994 Apr;12(1):29-34. doi: 10.1016/0920-9964(94)90081-7.
Plasma levels of interleukin (IL)-1 beta and IL-6 were measured in 60 acutely hospitalized psychiatric patients and in 60 healthy controls by enzyme-linked immunosorbent assay (ELISA). Almost no IL-6 was detected in the plasma of the patients or controls. The mean level of IL-1 beta was found to be significantly higher in schizophrenic patients than in their corresponding controls (P = 0.03). The acute schizophrenics, but not the group of chronic schizophrenics, contributed to this increase. No correlation with age, duration of illness or overt psychopathology was found. The neuroleptic medication did not prove to have a significant effect on the plasma IL-1 beta levels. There was no difference between non-psychotic affective disorder patients (N = 17) and the controls.
通过酶联免疫吸附测定法(ELISA)对60名急性住院精神科患者和60名健康对照者的血浆白细胞介素(IL)-1β和IL-6水平进行了检测。在患者或对照者的血浆中几乎未检测到IL-6。发现精神分裂症患者血浆中IL-1β的平均水平显著高于相应的对照组(P = 0.03)。急性精神分裂症患者而非慢性精神分裂症患者组导致了这种升高。未发现与年龄、病程或明显精神病理学存在相关性。抗精神病药物治疗对血浆IL-1β水平未显示出显著影响。非精神病性情感障碍患者(N = 17)与对照组之间无差异。